226 related articles for article (PubMed ID: 8514539)
1. Interleukin-1 modulatory effect on the action of chemotherapeutic drugs and localized irradiation of the lip, duodenum, and tumor.
Zaghloul MS; Dorie MJ; Kallman RF
Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):417-25. PubMed ID: 8514539
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 1 increases thymidine labeling index of normal tissues of mice but not the tumor.
Zaghloul MS; Dorie MJ; Kallman RF
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):805-11. PubMed ID: 8040027
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic enhancement in mice by clinically relevant dose and fractionation schedules of cis-diamminedichloroplatinum (II) and irradiation.
Bartelink H; Kallman RF; Rapacchietta D; Hart GA
Radiother Oncol; 1986 May; 6(1):61-74. PubMed ID: 3715061
[TBL] [Abstract][Full Text] [Related]
4. Schedule-dependent therapeutic gain from the combination of fractionated irradiation plus c-DDP and 5-FU or plus c-DDP and cyclophosphamide in C3H/Km mouse model systems.
Kallman RF; Rapacchietta D; Zaghloul MS
Int J Radiat Oncol Biol Phys; 1991 Feb; 20(2):227-32. PubMed ID: 1991683
[TBL] [Abstract][Full Text] [Related]
5. Effects of fractionated schedules of irradiation combined with cis-diamminedichloroplatinum II on the SCCVII/St tumor and normal tissues of the C3H/KM mouse.
Tanabe M; Godat D; Kallman RF
Int J Radiat Oncol Biol Phys; 1987 Oct; 13(10):1523-32. PubMed ID: 3624028
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1 modification of the effects of cyclophosphamide and fractionated irradiation.
Dorie MJ; Kallman RF; Cebulska-Wasilewska A
Int J Radiat Oncol Biol Phys; 1991 Feb; 20(2):311-4. PubMed ID: 1991694
[TBL] [Abstract][Full Text] [Related]
7. The effect of UCN-01 (7-hydroxystaurosporine), a potent inhibitor of protein kinase C, on fractionated radiotherapy or daily chemotherapy of a murine fibrosarcoma.
Tsuchida E; Urano M
Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):1153-61. PubMed ID: 9392558
[TBL] [Abstract][Full Text] [Related]
8. The effect of treatment in fractionated schedules with the combination of X-irradiation and six cytotoxic drugs on the RIF-1 tumor and normal mouse skin.
Lelieveld P; Scoles MA; Brown JM; Kallman RF
Int J Radiat Oncol Biol Phys; 1985 Jan; 11(1):111-21. PubMed ID: 4038500
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 dose, mouse strain, and end point as they affect protection of mouse jejunum.
Roberts DB; Travis EL; Tucker SL
Radiat Res; 1993 Jul; 135(1):56-63. PubMed ID: 8327661
[TBL] [Abstract][Full Text] [Related]
10. 5-Fluorouracil infusions and fractionated doses of radiation: studies with a murine squamous cell carcinoma.
Weinberg MJ; Rauth AM
Int J Radiat Oncol Biol Phys; 1987 Nov; 13(11):1691-9. PubMed ID: 3667376
[TBL] [Abstract][Full Text] [Related]
11. Radioprotection of the intestinal crypts of mice by recombinant human interleukin-1 alpha.
Wu SG; Miyamoto T
Radiat Res; 1990 Jul; 123(1):112-5. PubMed ID: 2371377
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the enhancement of tumor responses to fractionated irradiation by SR 4233 (tirapazamine) and by nicotinamide with carbogen.
Dorie MJ; Menke D; Brown JM
Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):145-50. PubMed ID: 8270435
[TBL] [Abstract][Full Text] [Related]
13. Combinations of single doses and fractionated treatments of cis-dichlorodiammineplatinum (II) and irradiation: effect on mouse lip mucosa.
Landuyt W; Ang KK; van der Schueren E
Br J Cancer; 1986 Oct; 54(4):579-86. PubMed ID: 3778802
[TBL] [Abstract][Full Text] [Related]
14. Combined effect of clinically relevant doses of emitefur, a new 5-fluorouracil derivative, and radiation in murine tumours.
Shibamoto Y; Murata R; Miyauchi S; Hirohashi M; Takagi T; Sasai K; Shibata T; Oya N; Takahashi M
Br J Cancer; 1996 Dec; 74(11):1709-13. PubMed ID: 8956782
[TBL] [Abstract][Full Text] [Related]
15. The importance of schedule and drug dose intensity in combinations of modalities.
Kallman RF
Int J Radiat Oncol Biol Phys; 1994 Feb; 28(3):761-71. PubMed ID: 8113123
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of murine MCa-4 carcinoma radioresponse by 9-amino-20(S)-camptothecin.
Kirichenko AV; Rich TA; Newman RA; Travis EL
Cancer Res; 1997 May; 57(10):1929-33. PubMed ID: 9157987
[TBL] [Abstract][Full Text] [Related]
17. Lack of differential radiosensitization of hypoxic cells in a mouse tumor at low radiation doses per fraction by cisplatin.
Sun JR; Brown JM
Radiat Res; 1993 Feb; 133(2):252-6. PubMed ID: 8438067
[TBL] [Abstract][Full Text] [Related]
18. Induction thermochemotherapy increases therapeutic gain factor for the fractionated radiotherapy given to a mouse fibrosarcoma.
Kuroda M; Urano M; Nishimura Y; Reynolds R
Int J Radiat Oncol Biol Phys; 1997 May; 38(2):411-7. PubMed ID: 9226330
[TBL] [Abstract][Full Text] [Related]
19. Erbulozole (P.I.N.N.) (R 55 104) encapsulated into cyclodextrins: has it a combined antitumoral and radioprotective potential?
Distelmans W; Van Ginckel R; Vanherck W; Willebrords R; Wouters L; De Brabander M; Mesens J
Anticancer Res; 1991; 11(1):253-6. PubMed ID: 2018359
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 1 protects against the lethal effects of irradiation of mice but has no effect on tumors in the same animals.
Dorie MJ; Allison AC; Zaghloul MS; Kallman RF
Proc Soc Exp Biol Med; 1989 May; 191(1):23-9. PubMed ID: 2654945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
